combretastatin has been researched along with Carcinoma, Lewis Lung in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haselwandter, CA; Kardar, M; Kohandel, M; Sengupta, S; Sivaloganathan, S | 1 |
| Ahn, BZ; Hong, DH; Kim, HM; Kim, Y; Nam, NH; You, YJ | 1 |
| Capila, I; Eavarone, D; Kiziltepe, T; Sasisekharan, R; Sengupta, S; Watson, N; Zhao, G | 1 |
3 other study(ies) available for combretastatin and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Quantitative model for efficient temporal targeting of tumor cells and neovasculature.
Topics: Algorithms; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bibenzyls; Biological Availability; Carcinoma, Lewis Lung; Computer Simulation; Doxorubicin; Drug Delivery Systems; Drug Synergism; Liposomes; Melanoma, Experimental; Mice; Models, Biological; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Time Factors; Treatment Outcome | 2011 |
Synthesis and anti-tumor activity of novel combretastatins: combretocyclopentenones and related analogues.
Topics: Animals; Antineoplastic Agents; Bibenzyls; Carcinoma, Lewis Lung; Cyclopentanes; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Mice; Stereoisomerism; Stilbenes; Structure-Activity Relationship; Tumor Cells, Cultured | 2002 |
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Bibenzyls; Carcinoma, Lewis Lung; Coculture Techniques; Doxorubicin; Drug Delivery Systems; Drug Therapy, Combination; Endothelial Cells; Humans; Melanoma, Experimental; Mice; Nanotechnology; Neoplasms; Neovascularization, Pathologic; Stilbenes; Time Factors; Tissue Distribution | 2005 |